跳至主要内容
临床试验/JPRN-UMIN000025083
JPRN-UMIN000025083已完成4 期

A study of long-term efficacy and safety of calcipqotriol hydrate/betamethasone dipropionate ester fixed dose combination product in patients with psoriasis vulgaris - A study of long-term efficacy and safety of calcipqotriol hydrate/betamethasone dipropionate ester fixed dose combination product in patients with psoriasis vulgaris

Fukuoka University0 个研究点目标入组 100 人开始时间: 2017年5月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) pregnant, or possibly pregnant women 2) subjects contraindicated by package insert 3) subjects judged unsuitable by physicians 4) subjects who are going to receive oral or injective steroid, cyclosporine, methotrexate, biologics, ultraviolet therapy, herbal medication against psoriasis within the trial period., 5) subjects who used Dovobet within 4 weeks before starting the trial.

研究者

相似试验